Of note, we show that CaSR activation increased cytosolic calcium, and reduced intracellular cAMP levels and mTOR activity thus improving the principal dysregulations of signaling molecules considered the most proximal events in the pathogenesis of ADPKD, making CaSR a possible therapeutic target candidate. Here, MTOR is linked to autosomal dominant polycystic kidney disease.